Reverse DCF
What growth does the market imply for ASTRAZEN?
Working backwards from the current price to find the FCF growth assumption baked in.
very aggressive
26.8% implied annual FCF growth
The market is pricing in exceptional growth that only a handful of companies sustain for a decade. For context, this company has historically grown at 18.0%. High execution risk.
Current Price
₹8,489
Historical Growth
18.0%
FCF Yield
0.89%
Price / FCF
111.8x
Plain English
To justify today's price of $8489.00, ASTRAZEN.NS needs to grow its free cash flow at 26.8% per year for the next 10 years. That is 8.8% faster than its historical growth rate of 18.0%. At its historical growth rate, the stock would take 19 years to justify today's price. The market is effectively paying for a perfect future.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| GDP rate | 10.0% | ₹2,368 | -72.1% |
| Half implied | 13.4% | ₹3,059 | -64.0% |
| Historical | 18.0% | ₹4,348 | -48.8% |
| Implied | 26.8% | ₹8,466 | -0.3% |
At Historical Growth Rate
It would take 19 years for ASTRAZEN to organically grow into today's price assuming its historical FCF growth of 18.0%.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, Monte Carlo, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.